SCHEMBL20346

SCHEMBL20346

OB(O)c1cccc2ncccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
POLB P06746 1/20 0.44
CYP3A4 P08684 2/20 0.42
LMNA P02545 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
BLM P54132 1/20 0.41
HIF1A Q16665 1/20 0.41
PABPC1 P11940 2/20 0.40
EIF4H Q15056 2/20 0.40
P2RX7 Q99572 1/20 0.40
CYP1A2 P05177 1/20 0.40
ERN1 O75460 2/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956251 1.00 MAPT (0.52) MAPTKDM4EMEN1KMT2APOLB
SCHEMBL22534519 0.89 MAPT (0.48) MAPTKDM4EMEN1KMT2APOLB
SCHEMBL16633605 0.88 MAPT (0.52) MAPTKDM4EMEN1KMT2APOLB
SCHEMBL482068 0.86 NCF1 (0.50) MAPTKDM4EMEN1KMT2ALMNA
SCHEMBL13740419 0.83 NCOA1 (0.41) MAPTKDM4EMEN1KMT2ACYP3A4
SCHEMBL1670719 0.79 KDM4E (0.57) MAPTKDM4EMEN1KMT2ACYP3A4
SCHEMBL29955571 0.78 MAPT (0.56) MAPTKDM4EMEN1KMT2APOLB
SCHEMBL29277674 0.78 NCF1 (0.43) MAPTKDM4EMEN1KMT2ACYP3A4
SCHEMBL29956653 0.77 MEN1 (0.47) MAPTKDM4EMEN1KMT2ACYP3A4
SCHEMBL20600552 0.76 KDM4E (0.52) MAPTKDM4EMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
US-11737481-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-08-29 US claimed
US-20220264914-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-08-25 US claimed
WO-2022159439-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2022-07-28 WO claimed
US-20220225646-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-9096856-B2 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2015-08-04 US claimed
WO-2015028711-A1 METHOD FOR DETECTING TRANSPARENT EXOPOLYMER PARTICLES IN A WATER SAMPLE KEMIRA OYJ (FI) 2015-03-05 WO claimed
US-20130184160-A1 NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-07-18 US claimed
EP-2485678-A1 COFERONS AND METHODS OF MAKING AND USING THEM Cornell University (US) 2012-08-15 EP claimed
US-20110144187-A1 APTAMER INHIBITION OF THROMBUS FORMATION GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION 2011-06-16 US claimed
EP-2310054-A2 APTAMER INHIBITION OF THROMBUS FORMATION Georgia State University Research Foundation, Inc. (US) 2011-04-20 EP claimed
WO-2011043817-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2011-04-14 WO claimed
EP-2176277-A2 NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF Georgia State University Research Foundation, Inc. (US) 2010-04-21 EP claimed
WO-2010019847-A2 APTAMER INHIBITION OF THROMBUS FORMATION GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-02-18 WO claimed
WO-2009012363-A2 NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-01-22 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184160-A1 NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF TENT4A, PABPC4, NUDT21 MAPT 3266/4885KDM4E 4374/4885MEN1 2021/4885
US-20110144187-A1 APTAMER INHIBITION OF THROMBUS FORMATION FGB, F13B, GP6 MAPT 4265/4885KDM4E 3714/4885MEN1 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.